{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T13:12:28Z","timestamp":1693833148646},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.dsx.2018.12.015","type":"journal-article","created":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T06:05:37Z","timestamp":1545545137000},"page":"925-931","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of hazardous elements of metabolic syndrome in hypertensive patients to defend them from cardiovascular risk in tribal region"],"prefix":"10.1016","volume":"13","author":[{"given":"Hemakshi E.","family":"Chaudhari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sativa D.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.dsx.2018.12.015_bib1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/oxfordjournals.eurheartj.a015434","article-title":"The burden of cardiovascular diseases mortality in europe: task force of the european society of cardiology on cardiovascular mortality and morbidity statistics in europe","volume":"18","author":"Sans","year":"1997","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.dsx.2018.12.015_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192372","article-title":"Prevalence of metabolic syndrome and its risk factors in Kerala, South India: analysis of a community based cross-sectional study","volume":"13","author":"Harikrishnan","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.dsx.2018.12.015_bib3","unstructured":"Alcohol, wine and cardiovascular disease, two sides of the same coin."},{"key":"10.1016\/j.dsx.2018.12.015_bib4","series-title":"Heart disease and occupational risk factors in the Canadian population: an exploratory study using the Canadian community health survey. Safety and health at work","author":"Nowrouzi-Kia","year":"2017"},{"issue":"15","key":"10.1016\/j.dsx.2018.12.015_bib5","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/CIR.0b013e3181f432c3","article-title":"American Heart Association Council on Cardiovascular Nursing. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association","volume":"122","author":"Piano","year":"2010","journal-title":"Circulation"},{"issue":"6_suppl","key":"10.1016\/j.dsx.2018.12.015_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/0269881105058375","article-title":"Metabolic syndrome and cardiovascular disease","volume":"19","author":"Citrome","year":"2005","journal-title":"J\u00a0Psychopharmacol"},{"issue":"8","key":"10.1016\/j.dsx.2018.12.015_bib7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.4070\/kcj.2003.33.8.645","article-title":"Metabolic syndrome and cardiovascular disease","volume":"33","author":"Cha","year":"2003","journal-title":"Korea Circ J"},{"issue":"7","key":"10.1016\/j.dsx.2018.12.015_bib8","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2337\/diacare.28.7.1769","article-title":"Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence","volume":"28","author":"Ford","year":"2005","journal-title":"Diabetes Care"},{"issue":"20","key":"10.1016\/j.dsx.2018.12.015_bib9","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1161\/CIRCULATIONAHA.105.539528","article-title":"Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus","volume":"112","author":"Wilson","year":"2005","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.dsx.2018.12.015_bib10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2011.08.080","article-title":"Pre-diabetes, metabolic syndrome, and cardiovascular risk","volume":"59","author":"Grundy","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5\u20136","key":"10.1016\/j.dsx.2018.12.015_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A\u00a0comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis Model Mech"},{"issue":"6","key":"10.1016\/j.dsx.2018.12.015_bib12","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.2337\/dc06-2236","article-title":"Metabolic syndrome in hypertensive patients: correlation between anthropometric data and laboratory findings","volume":"30","author":"Bulh\u00f5es","year":"2007","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.dsx.2018.12.015_bib13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.CIR.0000112379.88385.67","article-title":"Clinical management of metabolic syndrome: report of the American Heart Association\/National Heart, Lung, and Blood Institute\/American Diabetes Association conference on scientific issues related to management","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"issue":"Supplement1","key":"10.1016\/j.dsx.2018.12.015_bib14","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.5551\/jat.21_Sup.1-S31","article-title":"Metabolic syndrome and cardiovascular diseases in Korea","volume":"21","author":"Suh","year":"2014","journal-title":"J\u00a0Atherosclerosis Thromb"},{"issue":"4","key":"10.1016\/j.dsx.2018.12.015_bib15","doi-asserted-by":"crossref","first-page":"18B","DOI":"10.1016\/S0002-9149(98)00033-2","article-title":"Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome","volume":"81","author":"Grundy","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.dsx.2018.12.015_bib16","series-title":"Measurement of atherogenic lipoproteins in cardiovascular risk assessment. InCardiovascular Biomarkers","first-page":"497","author":"Dunbar","year":"2006"},{"issue":"2","key":"10.1016\/j.dsx.2018.12.015_bib17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.atherosclerosis.2003.12.022","article-title":"The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study","volume":"173","author":"Ford","year":"2004","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.dsx.2018.12.015_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/07315724.1983.10719931","article-title":"Effects of dietary magnesium on the development of hypertension in the spontaneously hypertensive rat","volume":"2","author":"Berthelot","year":"1983","journal-title":"J\u00a0Am Coll Nutr"},{"issue":"9426","key":"10.1016\/j.dsx.2018.12.015_bib19","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.dsx.2018.12.015_bib20","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1161\/CIRCRESAHA.116.307547","article-title":"Cardiovascular disease in women: clinical perspectives","volume":"118","author":"Garcia","year":"2016","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.dsx.2018.12.015_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1013797722156","article-title":"Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons","volume":"7","author":"Lakatta","year":"2002","journal-title":"Heart Fail Rev"},{"issue":"17","key":"10.1016\/j.dsx.2018.12.015_bib22","doi-asserted-by":"crossref","first-page":"R741","DOI":"10.1016\/j.cub.2012.07.024","article-title":"Ageing as a risk factor for disease","volume":"22","author":"Niccoli","year":"2012","journal-title":"Curr Biol"},{"key":"10.1016\/j.dsx.2018.12.015_bib23","series-title":"Aging and cardiovascular risk","author":"Costa","year":"2015"},{"issue":"8","key":"10.1016\/j.dsx.2018.12.015_bib24","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/CIRCRESAHA.111.246876","article-title":"The intersection between aging and cardiovascular disease","volume":"110","author":"North","year":"2012","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.dsx.2018.12.015_bib25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2796.2003.01229.x","article-title":"AusDiab Steering Committee. Waist circumference, waist\u2013hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults","volume":"254","author":"Dalton","year":"2003","journal-title":"J\u00a0Intern Med"},{"issue":"9","key":"10.1016\/j.dsx.2018.12.015_bib26","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.2337\/dc05-2482","article-title":"Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes","volume":"29","author":"Carr","year":"2006","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.dsx.2018.12.015_bib27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1161\/01.CIR.69.6.1065","article-title":"Family history of heart attack as an independent predictor of death due to cardiovascular disease","volume":"69","author":"Barrett-Connor","year":"1984","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.dsx.2018.12.015_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0033-0620(03)00087-2","article-title":"Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment","volume":"46","author":"Benowitz","year":"2003","journal-title":"Prog Cardiovasc Dis"},{"issue":"5","key":"10.1016\/j.dsx.2018.12.015_bib29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0033-0620(03)80002-6","article-title":"Smokeless tobacco and cardiovascular disease","volume":"45","author":"Asplund","year":"2003","journal-title":"Prog Cardiovasc Dis"},{"issue":"15","key":"10.1016\/j.dsx.2018.12.015_bib30","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/CIR.0b013e3181f432c3","article-title":"American Heart Association Council on Cardiovascular Nursing. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association","volume":"122","author":"Piano","year":"2010","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.dsx.2018.12.015_bib31","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jacc.2015.11.020","article-title":"Association of hemoglobin A1c levels with cardiovascular disease and mortality in Chinese patients with diabetes","volume":"67","author":"Wan","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.dsx.2018.12.015_bib32","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms","volume":"8","author":"Navab","year":"2011","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"10.1016\/j.dsx.2018.12.015_bib33","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1159\/000445552","article-title":"Correlation between the high density lipoprotein and its subtypes in coronary heart disease","volume":"38","author":"Gao","year":"2016","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"10.1016\/j.dsx.2018.12.015_bib34","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1476-5381.2012.02081.x","article-title":"Cardiovascular disease risk reduction by raising HDL cholesterol\u2013current therapies and future opportunities","volume":"167","author":"Ali","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.dsx.2018.12.015_bib35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00043798-199604000-00014","article-title":"Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a metaanalysis of population-based prospective studies","volume":"3","author":"Hokanson","year":"1996","journal-title":"J\u00a0Cardiovasc Risk"},{"issue":"2","key":"10.1016\/j.dsx.2018.12.015_bib36","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2337\/diab.41.2.202","article-title":"Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study","volume":"41","author":"Singer","year":"1992","journal-title":"Diabetes"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118305769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118305769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T23:18:01Z","timestamp":1556752681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402118305769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1871402118305769"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2018.12.015","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of hazardous elements of metabolic syndrome in hypertensive patients to defend them from cardiovascular risk in tribal region","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2018.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}